DE122005000029I2 - Synergistische kombinationen von Zidovudine, 1592u89 und 3TC - Google Patents

Synergistische kombinationen von Zidovudine, 1592u89 und 3TC

Info

Publication number
DE122005000029I2
DE122005000029I2 DE1996622386 DE69622386C DE122005000029I2 DE 122005000029 I2 DE122005000029 I2 DE 122005000029I2 DE 1996622386 DE1996622386 DE 1996622386 DE 69622386 C DE69622386 C DE 69622386C DE 122005000029 I2 DE122005000029 I2 DE 122005000029I2
Authority
DE
Germany
Prior art keywords
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1996622386
Other languages
English (en)
Other versions
DE69622386D1 (de
DE69622386T2 (de
Inventor
Walter Barry
Clair Heider St
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122005000029(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE122005000029I2 publication Critical patent/DE122005000029I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
DE1996622386 1995-03-30 1996-03-28 Synergistische kombinationen von Zidovudine, 1592u89 und 3TC Active DE122005000029I2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (1)

Publication Number Publication Date
DE122005000029I2 true DE122005000029I2 (de) 2006-04-27

Family

ID=26306774

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69622386T Expired - Lifetime DE69622386T2 (de) 1995-03-30 1996-03-28 Synergistische kombinationen von zidovudine, 1592u89 und 3tc
DE1996622386 Active DE122005000029I2 (de) 1995-03-30 1996-03-28 Synergistische kombinationen von Zidovudine, 1592u89 und 3TC
DE200512000029 Pending DE122005000029I1 (de) 1995-03-30 1996-03-28 Synergistische Kombinationen von Zidovudine, 1592u89 und 3tc.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69622386T Expired - Lifetime DE69622386T2 (de) 1995-03-30 1996-03-28 Synergistische kombinationen von zidovudine, 1592u89 und 3tc

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE200512000029 Pending DE122005000029I1 (de) 1995-03-30 1996-03-28 Synergistische Kombinationen von Zidovudine, 1592u89 und 3tc.

Country Status (36)

Country Link
US (1) US6417191B1 (de)
EP (1) EP0817637B1 (de)
JP (1) JP2954357B2 (de)
KR (1) KR100542536B1 (de)
CN (1) CN1103593C (de)
AP (1) AP652A (de)
AT (1) ATE220551T1 (de)
AU (1) AU715213B2 (de)
BR (3) BR9607851B1 (de)
CA (1) CA2216634C (de)
CZ (1) CZ295940B6 (de)
DE (3) DE69622386T2 (de)
DK (1) DK0817637T3 (de)
EA (1) EA000626B3 (de)
EE (1) EE04047B1 (de)
ES (1) ES2179193T3 (de)
FR (1) FR05C0022I2 (de)
GE (1) GEP20022647B (de)
HK (1) HK1009401A1 (de)
HU (1) HU224010B1 (de)
IL (1) IL117727A (de)
LU (1) LU91171I2 (de)
MX (1) MX9707316A (de)
MY (1) MY115461A (de)
NL (1) NL300195I2 (de)
NO (2) NO313787B1 (de)
NZ (1) NZ306419A (de)
OA (1) OA10616A (de)
PL (1) PL187085B1 (de)
PT (1) PT817637E (de)
RO (1) RO117995B1 (de)
SI (1) SI0817637T1 (de)
SK (1) SK283825B6 (de)
TR (1) TR199701074T1 (de)
UA (1) UA60293C2 (de)
WO (1) WO1996030025A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ333099A (en) * 1996-06-25 2000-06-23 Glaxo Group Ltd synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
BR9809127A (pt) * 1997-05-17 2000-08-01 Glaxo Group Ltd Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
AR040242A1 (es) * 2002-06-04 2005-03-23 Glaxo Group Ltd Composiciones farmaceuticas
ATE398455T1 (de) 2003-01-14 2008-07-15 Gilead Sciences Inc Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
EP1608629A1 (de) 2003-03-24 2005-12-28 F. Hoffmann-La Roche Ag Benzylpyridazinone als inhibitoren der reversen transkriptase
US20070202119A1 (en) 2003-10-24 2007-08-30 Ashdown Martin L Method Of Therapy
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
CN101291905A (zh) 2005-10-19 2008-10-22 弗·哈夫曼-拉罗切有限公司 苯乙酰胺nnrt抑制剂
KR101475091B1 (ko) 2006-12-13 2014-12-22 에프. 호프만-라 로슈 아게 비뉴클레오시드 역전사 효소 억제제로서 2-(피페리딘-4-일)-4-페녹시- 또는 페닐아미노-피리미딘 유도체
SI2120878T1 (sl) * 2007-02-09 2014-12-31 Alphapharm Pty Ltd Dozirna oblika, ki vsebuje dve aktivni farmacevtski sestavini v različnih fizičnih oblikah
EP2982978A1 (de) 2009-05-27 2016-02-10 Immunaid Pty Ltd Verfahren zur behandlung von krankheiten
KR20170078868A (ko) 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 항바이러스 치료
EP3038607A2 (de) 2013-08-29 2016-07-06 Teva Pharmaceutical Industries Ltd. Einzeldosisform mit emtricitabin, tenofovir, darunavir und ritonavir und monolithische tablette mit darunavir und ritonavir
CA2942877A1 (en) 2014-04-08 2015-10-15 Nitzan SHAHAR Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN117164657A (zh) 2014-08-12 2023-12-05 莫纳什大学 定向淋巴的前药
WO2017041139A1 (en) 2015-09-08 2017-03-16 Monash University Lymph directing prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
AU2018324037A1 (en) * 2017-08-29 2020-04-16 Monash University Lymphatic system-directing lipid prodrugs
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
KR20220149534A (ko) 2020-02-05 2022-11-08 퓨어테크 엘와이티, 아이엔씨. 신경스테로이드의 지질 전구약물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
EP0639971B1 (de) * 1992-05-13 1999-09-22 The Wellcome Foundation Limited Therapeutische kombinationen
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
NZ333099A (en) 1996-06-25 2000-06-23 Glaxo Group Ltd synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
ATE230267T1 (de) 1996-06-25 2003-01-15 Glaxo Group Ltd Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
HK1009401A1 (en) 1999-09-10
EP0817637B1 (de) 2002-07-17
AP652A (en) 1998-06-19
IL117727A0 (en) 1996-07-23
OA10616A (en) 2001-03-15
JP2954357B2 (ja) 1999-09-27
CA2216634C (en) 2004-07-20
ATE220551T1 (de) 2002-08-15
NL300195I2 (nl) 2005-11-01
EA199700203A1 (ru) 1998-02-26
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
RO117995B1 (ro) 2002-12-30
DE69622386D1 (de) 2002-08-22
HUP9801571A2 (hu) 1999-01-28
AP9701089A0 (en) 1997-10-31
CN1103593C (zh) 2003-03-26
HU224010B1 (hu) 2005-04-28
LU91171I2 (fr) 2005-07-04
FR05C0022I1 (de) 2005-06-10
PL187085B1 (pl) 2004-05-31
NO974510L (no) 1997-09-29
DE69622386T2 (de) 2003-02-13
KR100542536B1 (ko) 2006-03-23
BR9607851A (pt) 1998-07-21
IL117727A (en) 1999-11-30
DK0817637T3 (da) 2002-11-11
DE122005000029I1 (de) 2005-10-06
SK129597A3 (en) 1998-07-08
SK283825B6 (sk) 2004-02-03
NO974510D0 (no) 1997-09-29
HUP9801571A3 (en) 2001-04-28
ES2179193T3 (es) 2003-01-16
MX9707316A (es) 1997-11-29
CA2216634A1 (en) 1996-10-03
AU5497296A (en) 1996-10-16
JPH10511682A (ja) 1998-11-10
MY115461A (en) 2003-06-30
EP0817637A1 (de) 1998-01-14
EE04047B1 (et) 2003-06-16
NO313787B1 (no) 2002-12-02
BRPI9607851B8 (pt) 2019-11-05
NO2005014I1 (no) 2005-06-06
CZ295940B6 (cs) 2005-12-14
CN1185110A (zh) 1998-06-17
EE9700240A (et) 1998-04-15
PL322532A1 (en) 1998-02-02
GEP20022647B (en) 2002-03-25
SI0817637T1 (en) 2002-10-31
BRPI9612992B1 (pt) 2020-08-04
NO2005014I2 (no) 2008-02-11
EA000626B1 (ru) 1999-12-29
BR9607851B1 (pt) 2009-01-13
FR05C0022I2 (de) 2005-10-21
CZ309097A3 (cs) 1998-05-13
EA000626B3 (ru) 2016-04-29
WO1996030025A1 (en) 1996-10-03
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
KR19980703420A (ko) 1998-11-05
UA60293C2 (uk) 2003-10-15
US6417191B1 (en) 2002-07-09
AU715213B2 (en) 2000-01-20
LU91171I9 (de) 2018-12-28

Similar Documents

Publication Publication Date Title
DE69622386D1 (de) Synergistische kombinationen von zidovudine, 1592u89 und 3tc
DE69415157D1 (de) Elektrochirurgischer prozessor und anwendung
DE69627513D1 (de) Kochgerät und dessen betriebsverfahren
BR9702553A (pt) Composição cosmética e utilização
DE69842004D1 (de) Substituierte 2-aminoacetamide und anwendung davon
DE69600316D1 (de) Haarkosmetische Zusammensetzung
DE69629987D1 (de) Funktelefone und Betriebsverfahren
BR9505368A (pt) Composição cosmética ou dermatogógico água-em-óleo
BR9609831A (pt) Composições cosméticas e/ou farmacêuticas antipruríticas
ATE257708T1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DE69624042D1 (de) TiO2 dotiertes, Ta2O5 enthaltendes dielektrisches Material und dieses enthaltende Bauteile
BR9611179A (pt) Composiç o em creme
BR9800753B1 (pt) composição cosmética e/ou dermatológica e uso de uma composição.
ATE228575T1 (de) Wirkstoffkombinationen
KR960030598U (ko) 이,미용원용가습장치
BR9611178A (pt) Composiç o em creme
DE59607418D1 (de) Haarbehandlungsmittel
FI963720A (fi) N-aryyli- ja N-alkyylisulfonyyliaminaalit tuholaisten torjunta-aineina
PT101949A (pt) Boneco com elevacao simultania de bracos, pernas e abertura de olhos
FR2761061B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
BR9508669A (pt) Novos derivados de taizoloÚ3,2-a¾quinolina e naftirina
KR970028220U (ko) 판박이식 매니큐어
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
KR970020586U (ko) 판박이식 메니큐어